 CARLSBAD, Calif., July 07, 2021 GLOBE NEWSWIRE -- SeaSpine Holdings Corporation NASDAQ: SPNE, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the FDA 510k clearance of its 7D Percutaneous Spine Module for minimally invasive surgery. This represents a new application and increased functionality for its 7D FlashTM Navigation System. This news follows SeaSpines recent acquisition of 7D Surgical, a Toronto-based company that develops advanced optical technologies and machine vision-based registration algorithms for surgical navigation to improve patient care. The Company is preparing a limited release of the Percutaneous Spine Module in the third quarter. 